Results 191 to 200 of about 66,698 (357)
Thyrotropin and norepinephrine stimulate the metabolism of phosphoinositides in FRTL‐5 thyroid cells [PDF]
Nancy J. Philp, Evelyn F. Grollman
openalex +1 more source
Abstract There is an abundance of high‐quality clinical data and resources for Alzheimer's disease (AD) in Korea. To investigate therapeutic targets and biomarkers, and to progress the AD research field in Korea by standardizing the dementia dataset in Korea, the Trial Ready Registry (TRR) and Dementia Platform Korea (DPK) were developed.
Haeng Jun Kim +16 more
wiley +1 more source
Early effects of radioactive iodine (I-131) therapy on liver function in patients with Graves' disease: a 48-h analysis. [PDF]
Hu RT, Li B.
europepmc +1 more source
ABSTRACT Donepezil hydrochloride, used to treat Alzheimer's disease, is typically initiated at a low dose and titrated to minimize gastrointestinal side effects. Despite its favorable safety profile, the patient developed severe anorexia, dehydration, and electrocardiographic abnormalities.
Nobuyuki Takahashi +4 more
wiley +1 more source
Transcriptional regulation of the thyrotropin-releasing hormone gene by leptin and melanocortin signaling [PDF]
Mark Harris +8 more
openalex +1 more source
Incidental Diagnosis of Fahr's Disease Following Severe Traumatic Brain Injury: A Case Report
ABSTRACT Fahr's disease is a rare idiopathic neurodegenerative disorder characterized by symmetrical calcifications in the basal ganglia and cerebellar dentate nuclei. Although it may present with diverse neuropsychiatric symptoms, a significant number of cases remain asymptomatic and are only identified incidentally through neuroimaging performed for ...
Hadi Ebrahimi +5 more
wiley +1 more source
Thymic hyperplasia in an adult with Graves disease. [PDF]
Roddy J, Dhage S, Syed AA.
europepmc +1 more source
Novel Genetic Findings in Stuve‐Wiedemann Syndrome: A Case Report and Review of Literature
ABSTRACT Stuve‐Wiedemann Syndrome (SWS) is a rare autosomal recessive condition, first reported in 1971 by Stuve and Wiedemann. It is associated with pathogenic or likely pathogenic homozygous or compound heterozygous variants in the Leukemia Inhibitory Factor Receptor (LIFR) gene.
Khalid Hamasalih Hamasharef +4 more
wiley +1 more source

